IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pharmstandard International S.A.

Q1 2017 Holdings

Filed 2017-05-12 | 5 holdings | $37.5K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2017-08-17) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Jounce Therapeutics(JNCEEUR)Common481116101$14.6K662,06338.8%
Protagonist Therapeutic, Inc.(PTGX)Common74366E102$12.6K982,27033.6%
Argos Therapeutics Inc.Common040221103$6.0K13,242,27916.0%
Argos Therapeutics Inc.CallACommon040221103$2.3K5,120,6046.2%
Proteon Therapeutics Inc.Common74371L109$2.0K1,165,3445.4%